← All companiesIImmunityBio, Inc.
IBRX - CIK 0001326110
ImmunityBio, Inc. net income by year
ImmunityBio, Inc. (IBRX) reported net income of -$351.50M for fiscal year 2025, as filed in its audited annual report with the SEC.
IBRX annual net income
IBRX net income 2013-2025
| Fiscal year | Net Income | Change |
|---|
| FY 2025 | -$351.50M | +15.0% |
| FY 2024 | -$413.60M | +29.2% |
| FY 2023 | -$583.90M | -39.9% |
| FY 2022 | -$417.30M | -19.3% |
| FY 2021 | -$349.80M | -57.7% |
| FY 2020 | -$221.85M | -40.6% |
| FY 2019 | -$157.78M | -64.0% |
| FY 2018 | -$96.23M | +0.2% |
| FY 2017 |
Net Income of similar companies
Frequently asked questions
How much profit does ImmunityBio, Inc. make?
ImmunityBio, Inc. (IBRX) reported net income of -$351.50M for fiscal year 2025, as filed in its audited annual report with the SEC.
How has ImmunityBio, Inc.'s net income changed over time?
Between fiscal 2013 and fiscal 2025, ImmunityBio, Inc.'s net income declined from -$2.05M to -$351.50M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.